Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 20
Filter
13.
Pediatr Dermatol ; 35(1): e64-e65, 2018 Jan.
Article in English | MEDLINE | ID: mdl-29164681

ABSTRACT

The first vaccine that shows significant potential in providing broad coverage against serogroup B meningococcal disease has recently been approved. Because of its newness, potential adverse events need to be reported. Here we report a case of urticarial vasculitis, a rare disease in children, in probable relationship with the novel vaccine.


Subject(s)
Meningococcal Infections/prevention & control , Meningococcal Vaccines/adverse effects , Neisseria meningitidis, Serogroup B/immunology , Vasculitis, Leukocytoclastic, Cutaneous/diagnosis , Child , Female , Histamine Antagonists/therapeutic use , Humans , Skin/pathology , Vasculitis, Leukocytoclastic, Cutaneous/etiology
SELECTION OF CITATIONS
SEARCH DETAIL
...